Search Results - Goldin, Mark

Fragmented central venous catheter retained for years with minimal symptoms by Mullan, Clancy W., Tariq, Umair, Goldin, Mark

Get full text Get full text Get full text

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors by Spyropoulos, Alex C., Giannis, Dimitrios, Goldin, Mark

Get full text Get full text Get full text

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review by Gianni, Panagiota, Goldin, Mark, Ngu, Sam, Zafeiropoulos, Stefanos, Geropoulos, Georgios, Giannis, Dimitrios

Get full text Get full text Get full text

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty by Shah, Sarav S., Satin, Alexander M., Mullen, James R., Merwin, Sara, Goldin, Mark, Sgaglione, Nicholas A.

Get full text Get full text Get full text

Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China by Shang, Hong, Han, Xiaoxu, Shi, Xuanling, Zuo, Teng, Goldin, Mark, Chen, Dan, Han, Bing, Sun, Wei, Wu, Hao, Wang, Xinquan, Zhang, Linqi

Get full text Get full text Get full text

Comprehensive Analysis of Pathogen-specific Antibody Response in Vivo Based on an Antigen Library Displayed on Surface of Yeast by Zuo, Teng, Shi, Xuanling, Liu, Zhonghua, Guo, Linlin, Zhao, Qing, Guan, Tianxia, Pan, Xianming, Jia, Na, Cao, Wuchun, Zhou, Boping, Goldin, Mark, Zhang, Linqi

Get full text Get full text Get full text

Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH by Spyropoulos, Alex C., Connors, Jean M., Douketis, James D., Goldin, Mark, Hunt, Beverley J., Kotila, Taiwo R., Lopes, Renato D., Schulman, Sam, the International Society on Thrombosis and Haemostasis

Get full text Get full text Get full text

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 by Giannis, Dimitrios, Barish, Matthew A., Goldin, Mark, Cohen, Stuart L., Kohn, Nina, Gianos, Eugenia, Chatterjee, Saurav, Lesser, Martin, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Spyropoulos, Alex C.

Get full text Get full text Get full text

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19 by Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.

Get full text Get full text Get full text

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients by Cohen, Stuart L., Gianos, Eugenia, Barish, Mathew A., Chatterjee, Saurav, Kohn, Nina, Lesser, Martin, Giannis, Dimitrios, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas G., Goldin, Mark E., Spyropoulos, Alex C.

Get full text Get full text Get full text

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19 by Goldin, Mark, Lin, Stephanie K., Kohn, Nina, Qiu, Michael, Cohen, Stuart L., Barish, Matthew A., Gianos, Eugenia, Diaz, Anise, Richardson, Safiya, Giannis, Dimitrios, Chatterjee, Saurav, Coppa, Kevin, Hirsch, Jamie S., Ngu, Sam, Firoozan, Sheila, McGinn, Thomas, Spyropoulos, Alex C.

Get full text Get full text Get full text

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial by Spyropoulos, Alex C., Goldin, Mark, Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Hiatt, William R., Halperin, Jonathan L., Maynard, Gregory, Steg, P. Gabriel, Weitz, Jeffrey I., Spiro, Theodore E., Lu, Wentao, Marsigliano, Jessica, Raskob, Gary E., Barnathan, Elliot S.

Get full text Get full text Get full text

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older by Ageno, Walter, Lopes, Renato D., Goldin, Mark, Yusen, Roger D., Albers, Gregory W., Elliott, Gregory C., Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory, Steg, Philippe Gabriel, Weitz, Jeffrey I., Suh, Eunyoung, Lu, Wentao, Barnathan, Elliot S., Raskob, Gary E., Spyropoulos, Alex C.

Get full text Get full text Get full text

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The... by Spyropoulos, Alex C., Goldin, Mark, Giannis, Dimitrios, Diab, Wassim, Wang, Janice, Khanijo, Sameer, Mignatti, Andrea, Gianos, Eugenia, Cohen, Marc, Sharifova, Gulru, Lund, Jeet M., Tafur, Alfonso, Lewis, Paul A., Cohoon, Kevin P., Rahman, Husneara, Sison, Cristina P., Lesser, Martin L., Ochani, Kanta, Agrawal, Nirav, Hsia, Judith, Anderson, Victoria E., Bonaca, Marc, Halperin, Jonathan L., Weitz, Jeffrey I.

Get full text Get full text Get full text

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry by Giannis, Dimitrios, Allen, Steven L., Tsang, James, Flint, Sarah, Pinhasov, Tamir, Williams, Stephanie, Tan, Gary, Thakur, Richa, Leung, Christian, Snyder, Matthew, Bhatia, Chirag, Garrett, David, Cotte, Christina, Isaacs, Shelby, Gugerty, Emma, Davidson, Anne, Marder, Galina S., Schnitzer, Austin, Goldberg, Bradley, McGinn, Thomas, Davidson, Karina W., Barish, Matthew A., Qiu, Michael, Zhang, Meng, Goldin, Mark, Matsagkas, Miltiadis, Arnaoutoglou, Eleni, Spyropoulos, Alex C.

Get full text Get full text Get full text